You searched for: eu exit medicine faq

1 result

Treatments for non-hospitalised patients at highest risk from COVID-19 infection aged 12 years and over: Update to supporting information for NHS111/IUC CAS service providers

Classification: Official Publication approval reference: C1583 9 February 2022, Version 1 Policy update The interim clinical commissioning policy on COVID-19 treatments for non-hospitalised patients has been updated to include: Additional treatment options: PF-07321332 (nirmatrelvir) plus ritonavir – marketing name is Paxlovid – an oral antiviral, which should be taken with five days of symptom onset; […]